{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tildrakizumab",
          "type": "Drug",
          "label": "Tildrakizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_risankizumab",
          "type": "Drug",
          "label": "Risankizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_brodalumab",
          "type": "Drug",
          "label": "Brodalumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_generalised_pustular_psoriasis",
          "type": "Disease",
          "label": "Generalised Pustular Psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_acitretin",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知对类似表型有效"
        },
        {
          "source": "drug_cyclosporine",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "临床证据支持"
        },
        {
          "source": "drug_methotrexate",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "用于其他类型银屑病，具有潜在效应"
        },
        {
          "source": "drug_infliximab",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "靶向抗体，有证据显示效果良好"
        },
        {
          "source": "drug_adalimumab",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "抗体类药物在相似表型中表现出效用"
        },
        {
          "source": "drug_etanercept",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "已在临床试验中展示相关性"
        },
        {
          "source": "drug_ustekinumab",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "新型靶向治疗，报告疗效"
        },
        {
          "source": "drug_secukinumab",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "靶向IL-17，有潜在应用"
        },
        {
          "source": "drug_tildrakizumab",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "临床显示良好，针对IL-23"
        },
        {
          "source": "drug_risankizumab",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "相似机制药物的持续研究"
        },
        {
          "source": "drug_brodalumab",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "基于IL-17作用，具备潜力"
        },
        {
          "source": "drug_apremilast",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "小分子，具有其他类型鳞屑病的疗效可能"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.765,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.7,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "已知对类似表型有效"
            ],
            "safety_risk": [
              "未见潜在安全性风险"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H2",
          "score": 0.785,
          "components": {
            "mechanism_fit": 0.85,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.68,
            "indication_plausibility": 0.75,
            "safety_risk": 0.1,
            "graph_bonus": 0.18,
            "conflict_penalty": 0.0
          },
          "graph_signals": {
            "support_weight": 0.85,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "临床证据支持该疗法对于相似表型有效"
            ],
            "safety_risk": [
              "没有显示的安全性风险"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H3",
          "score": 0.704,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.7,
            "safety_risk": 0.25,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.0
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "用于其他类型银屑病，具有潜在效应"
            ],
            "safety_risk": [
              "可能存在较高的长期安全性风险"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "长期效果及安全性需更多研究"
          ]
        },
        {
          "hypothesis_id": "H4",
          "score": 0.72,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.75,
            "safety_risk": 0.1,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.0
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "靶向抗体，有证据显示效果良好"
            ],
            "safety_risk": [
              "没有显示的安全性风险"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H5",
          "score": 0.69,
          "components": {
            "mechanism_fit": 0.72,
            "class_prior": 0.55,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.7,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.0
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "抗体类药物在相似表型中表现出效用"
            ],
            "safety_risk": [
              "潜在的安全问题需被考虑"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需进一步研究相似疾病中的应用"
          ]
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_disjoint_path",
            "from": "drug_acitretin",
            "via": [],
            "to": "d_generalised_pustular_psoriasis",
            "success_criteria": "形成至少2条不相交支持路径",
            "assignee": "Proponent"
          },
          {
            "type": "stress_test_safety",
            "topic": "长期安全性",
            "expectation": "如有潜在风险，则需理论验证",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "评估现有疗法对长期效果的持久性",
          "不同药物影响机制的优劣对比"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "add_disjoint_path",
            "from": "drug_cyclosporine",
            "via": [],
            "to": "d_generalised_pustular_psoriasis",
            "success_criteria": "审议该药物的适应症及长期应用效果",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "深入探讨针对该病的特效治疗选择",
          "实践中药物组合的应用与效果"
        ]
      }
    ],
    "pruned_hypotheses": [],
    "new_subhypotheses": [],
    "seed_request": {
      "should_regenerate": false,
      "reason": "路径独立性不足，缺乏足够的不相交证据支持，需补充新的机制路径评估。",
      "n": 4
    }
  }
}